SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer

• 收藏
• 分享

专利权人:

Günther Lametschwandtner

发明人:

Günther Lametschwandtner,Hans Loibner,Manfred Schuster,Isabella Haslinger,Sandra Seidl

申请号：

US13977453

公开号：

US09186373B2

申请日:

2011.12.27

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The invention relates to a method for the immune activation of NK cells by the reduction or inhibition of the Cbl-b function in said cells. This stimulates the congenital immune system and thus permits the therapy of appropriate diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/